Propranolol Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Propranolol General Information
Description
Provider of pharmaceutical products. The company provides generic propranolol hydrochloride extended release capsules used to treat hypertension.
Contact Information
Corporate Office
- 909 Third Avenue
- New York, NY 10022
- United States
Corporate Office
- 909 Third Avenue
- New York, NY 10022
- United States
Propranolol Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Propranolol Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Propranolol FAQs
-
Where is Propranolol headquartered?
Propranolol is headquartered in New York, NY.
-
What industry is Propranolol in?
Propranolol’s primary industry is Drug Delivery.
-
Is Propranolol a private or public company?
Propranolol is a Private company.
-
What is Propranolol’s current revenue?
The current revenue for Propranolol is
. -
Who are Propranolol’s investors?
Forest Laboratories has invested in Propranolol.
-
When was Propranolol acquired?
Propranolol was acquired on 09-Jul-2014.
-
Who acquired Propranolol?
Propranolol was acquired by Catalent.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »